Tyler Simpson is the Director and Precision Medicine Team Lead at Amgen, bringing over 12 years of pharmaceutical and biotech experience to their role. Previously, Tyler served as a Clinical Biomarker Lead at Bristol Myers Squibb, where they designed biomarker testing strategies and led translational development efforts for immunotherapy-related projects. Tyler also held senior research positions at Jounce Therapeutics and Memorial Sloan Kettering Cancer Center, contributing significantly to the field of tumor immunology and checkpoint blockade. They earned a Ph.D. in Cell and Developmental Biology from Weill Cornell Graduate School of Medical Sciences and a Bachelor's Degree with Honors in Genetics from The University of British Columbia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices